Get started
BLUESTAR ADISSEO COMPANYBB

BLUESTAR ADISSEO COMPANY

10.95CNYD
−0.04−0.36%
At close at 08:50 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

600299 fundamentals

Key facts

Market capitalization‪29.47 B‬CNY
Dividend yield (indicated)1.64%
Price to earnings Ratio (TTM)24.47
Basic EPS (TTM)0.45CNY
Founded1999
Employees (FY)‪2.93 K‬
CEOJean-Marc Dublanc
Websitebluestar-adisseo.com
About

Bluestar Adisseo Co. engages in the research and development, production, and marketing of animal nutrition additives. It operates through Health and Nutrition segment. Its products include Rhodimet, Smartamine and MetaSmart, Microvit, Rovabio, Selisseo, AdiSodium, and Alterion. The company was founded on May 31, 1999 and is headquartered in Beijing, China.

Ownership
‪‪2.68 B‬‬
Closely held shares
‪‪2.33 B‬‬ (86.75%)
Free Float shares
‪‪355.42 M‬‬ (13.25%)
Closely held shares
‪‪2.33 B‬‬ (86.75%)
Free Float shares
‪‪355.42 M‬‬ (13.25%)
Capital structure
Market cap
‪‪29.47 B‬‬
Debt
‪‪1.37 B‬‬
Minority interest
‪‪27.39 M‬‬
Cash & equivalents
‪‪1.27 B‬‬
Enterprise value
‪‪29.61 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪29.47 B‬‬
Price to earning ratio (P/E)
24.47x
Price to sales ratio (P/S)
1.91x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
24.47x
Price to sales ratio (P/S)
1.91x
Valuation ratios
‪0.00‬
‪0.55‬
‪1.10‬
‪1.65‬
‪2.20‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪110.00‬
‪220.00‬
‪330.00‬
‪440.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪2%‬
‪4%‬
‪6%‬
‪8%‬
‪10%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪1.10 B‬‬
‪‪2.20 B‬‬
‪‪3.30 B‬‬
‪‪4.40 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪1.10 B‬‬
‪‪2.20 B‬‬
‪‪3.30 B‬‬
‪‪4.40 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪1.10 B‬‬
‪‪2.20 B‬‬
‪‪3.30 B‬‬
‪‪4.40 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Functional Products
Special Products
By country
Period: 2024
Europe, Indian Subcontinent, Middle East and Africa
Latin America
North America
China
Asia Pacific (excluding China)
Other

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪1.10 B‬‬
‪‪2.20 B‬‬
‪‪3.30 B‬‬
‪‪4.40 B‬‬
Actual
Estimate
Earnings
Next:Apr 24, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪0.05‬
‪0.10‬
‪0.15‬
‪0.20‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
40.08%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.55%
Next payment
0.06
Next ex-date
Mar 28, 2025
Dividend history
‪0.75%‬
‪1.05%‬
‪1.35%‬
‪1.65%‬
‪1.95%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.05‬
‪0.10‬
‪0.15‬
‪0.20‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪600.00 M‬‬
‪‪1.20 B‬‬
‪‪1.80 B‬‬
‪‪2.40 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪4.50 B‬‬
‪‪9.00 B‬‬
‪‪13.50 B‬‬
‪‪18.00 B‬‬
Assets
Liabilities